Vir Biotechnology, Inc. (VIR)

9.25 -1.04 (-10.11%) USD  |  NASDAQ  |  May 07, 15:44
More

Vir Biotechnology Annual Revenue Estimates

Annual Revenue Estimates Chart

View Annual Revenue Estimates for VIR.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Annual Revenue Estimates Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Annual Revenue Estimates Range, Past 5 Years

View Annual Revenue Estimates Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Annual Revenue Estimates Benchmarks

View Annual Revenue Estimates Benchmarks
Start Trial
Hims & Hers Health, Inc. Upgrade
Alnylam Pharmaceuticals, Inc. Upgrade
BioMarin Pharmaceutical, Inc. Upgrade
Gossamer Bio, Inc. Upgrade
Sensei Biotherapeutics, Inc. Upgrade